Cytotoxicity of mitomycin C and carboquone combined with hyperthermia against hypoxic tumor cells in vitro.
Enhancement of the cytotoxicity of mitomycin C (MMC) and carboquone (CQ) by hypoxia at elevated temperature was examined using the SDI test of mouse Sarcoma 180 and Ehrlich cells and clonogenic assay of HeLa cells. When Sarcoma 180 and Ehrlich cells were incubated at 43 degrees C for 2-10 h, the hyperthermic effect was enhanced by hypoxia. The succinate dehydrogenase activity of the cells was reduced by hyperthermia to a greater extent in the presence of hypoxia (O2:5%) than under conditions of aeration (O2:20%). When the cells were exposed to various concentrations of MMC and CQ, under hypoxia, activity of the drugs was enhanced compared to the findings under conditions of aeration. The enhancement was prominent in case of drugs and hyperthermia combined. Clonogenicity of hypoxic HeLa cells was also reduced to a greater extent with this combination than in case of aerated cells. We tentatively speculate that hyperthermo-chemotherapy using MMC and CQ has a potential to attack selectively hypoxic cells present in a solid tumor.
Sakaguchi
Y
Y
Cancer Center of Kyushu University Hospital, Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Kohnoe
S
S
Emi
Y
Y
Maehara
Y
Y
Kusumoto
T
T
Sugimachi
K
K
D000332:Aerobiosis; D000693:Anaerobiosis; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D002225:Carbazilquinone / Q000008:administration & dosage; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D015687:Cell Hypoxia / Q000187:drug effects* / Q000502:physiology; D003131:Combined Modality Therapy; D006367:HeLa Cells; D006801:Humans; D006979:Hyperthermia, Induced; D051379:Mice; D016685:Mitomycin / Q000008:administration & dosage; D012510:Sarcoma 180 / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D014407:Tumor Cells, Cultured
D002225:Carbazilquinone; D016685:Mitomycin